Abstract
The present study investigated possible relationships between left ventricular mass, intima-media thickness of the carotid artery (IMT), total arterial compliance, and lipid status in a population sample of 58 apparently healthy subjects aged 20 to 69. By stepwise multiple regression analysis, including age, blood pressure, and smoking, left ventricular mass index, measured by M-mode echocardiography, increased by 13.0 g/m2 for each 1 standard deviation (SD=0.11 μM, r=0.60, P<0.01) increase in plasma malondialdehyde and 9.50 g/m2 per SD increase in plasma 8-iso-prostaglandin F2α in women only (SD=8.88 ng/L, r=0.44, P=0.01). Each 1-SD (SD=0.27 g/L) increase in apolipoprotein B was associated with a 63 μm increase in IMT (r=0.47, P=0.01) and a 0.27 mL/min/m2/mm Hg (r=−0.60, P<0.01) decrease in stroke index/pulse pressure ratio, reflecting total arterial compliance in women. In men, each 1-SD increase in the proportion of stearic acid (18∶0) in serum cholesterol esters (SD=0.12 percent units) reduced the transmitral E/A ratio, measured by Doppler echocardiography, reflecting left ventricular diastolic function, by 0.10 units (r=−0.29, P<0.05). Thus, important cardiovascular characteristics, such as left ventricular mass, left ventricular diastolic function, carotid IMT, and total arterial compliance, were independently predicted by indices of lipid metabolism and peroxidation in apparently healthy subjects.
Similar content being viewed by others
Abbreviations
- AVPD:
-
atrio-ventricular valve plane displacement
- CHD:
-
coronary heart disease
- EF:
-
ejection fraction
- IMT:
-
intima-media thickness
- 8-iso-PGF2α :
-
8-iso-prostaglandin F2α
- LVEDD:
-
left ventricular diameter in end-diastole
- LVESD:
-
left ventricular diameter in end-systole
- LVMI:
-
left ventricular mass index
- MDA:
-
malondialdehyde
- PL:
-
phospholipid
- PP:
-
pulse pressure=systolic blood pressure—diastolic blood pressure
- SI:
-
stroke index
References
Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B., and Castelli, W.P. (1990) Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study, N. Engl. J. Med. 322, 1561–1566.
O’Leary, D.H., Polak, J.F., Kronmal, R.A., Manolio, T.A., Burke, G.L., and Wolfson, S.K., Jr. (1999) Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults. Cardiovascular Health Study Collaborative Research Group, N. Engl. J. Med. 340, 14–22.
Dart, A.M., Lacombe, F., Yeoh, J.K., Cameron, J.D., Jennings, G.L., Laufer, E., and Esmore, D.S. (1991) Aortic Distensibility in Patients with Isolated Hypercholesterolaemia, Coronary Artery Disease, or Cardiac Transplant, Lancet 338, 270–273.
Davis, P.H., Dawson, J.D., Mahoney, L.T., and Lauer, R.M. (1999) Increased Carotid Intimal-Medial Thickness and Coronary Calcification Are Related in Young and Middle-Aged Adults. The Muscatine Study, Circulation 100, 838–842.
Schwartzkopff, B., Motz, W., Vogt, M., and Strauer, B.E. (1993) Heart Failure on the Basis of Hypertension, Circulation 87 (Suppl.), IV66–72.
Jousilahti, P., Vartiainen, E., Pekkanen, J., Tuomilehto, J., Sundvall, J., and Puska, P. (1998) Serum Cholesterol Distribution and Coronary Heart Disease Risk: Observations and Predictions Among Middle-Aged Population in Eastern Finland, Circulation 97, 1087–1094.
Frayn, K.N., Williams, C.M., and Arner, P. (1996) Are Increased Plasma Non-esterified Fatty Acid Concentrations a Risk Marker for Coronary Heart Disease and Other Chronic Diseases? Clin. Sci. 90, 243–253.
Castelli, W.P., Doyle, J.T., Gordon, T., Hames, C.G., Hjortland, M.C., Hulley, S.B., Kagan, A., and Zukel, W.J. (1977) HDL Cholesterol and Other Lipids in Coronary Heart Disease. The Cooperative Lipoprotein Phenotyping Study, Circulation 55, 767–772.
Simon, J.A., Hodgkins, M.L., Browner, W.S., Neuhaus, J.M., Bernert, J.T., Jr., and Hulley, S.B. (1995) Serum Fatty Acids and the Risk of Coronary Heart Disease, Am. J. Epidemiol. 142, 469–476.
Miettinen, T.A., Naukkarinen, V., Huttunen, J.K., Mattila, S., and Kumlin, T. (1982) Fatty-Acid Composition of Serum Lipids Predicts Myocardial Infarction, Br. Med. J. 285, 993–996.
Sundström, J., Lind, L., Nyström, N., Zethelius, B., Andrén, B., Hales, C.N., and Lithell, H.O. (2000) Left Ventricular Concentric Remodeling Rather Than Left Ventricular Hypertrophy Is Related to the Insulin Resistance Syndrome in Elderly Men, Circulation 101, 2595–2600.
Jayakumari, N., Ambikakumari, V., Balakrishnan, K.G., and Iyer, K.S. (1992) Antioxidant Status in Relation to Free Radical Production During Stable and Unstable Anginal Syndromes, Atherosclerosis 94, 183–190.
Chandra, M., Chandra, N., Agrawal, R., Kumar, A., Ghatak, A., and Pandey, V.C. (1994) The Free Radical System in Ischemic Heart Disease, Int. J. Cardiol. 43, 121–125.
Diaz-Velez, C.R., Garcia-Castineiras, S., Mendoza-Ramos, E., and Hernandez-Lopez, E. (1996) Increased Malondialdehyde in Peripheral Blood of Patients with Congestive Heart Failure, Am. Heart J. 131, 146–152.
Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J., and Tedgui, A. (1998) Elevated Levels of 8-Iso-prostaglandin F2α in Pericardial Fluid of Patients with Heart Failure: A Potential Role for in vivo Oxidant Stress in Ventricular Dilatation and Progression to Heart Failure, Circulation 97, 1536–1539.
Keith, M., Geranmayegan, A., Sole, M.J., Kurian, R., Robinson, A., Omran, A.S., and Jeejeebhoy, K.N. (1998) Increased Oxidative Stress in Patients with Congestive Heart Failure, J. Am. Coll. Cardiol. 31, 1352–1356.
Dhalla, A.K., Hill, M.F., and Singal, P.K. (1996) Role of Oxidative Stress in Transition of Hypertrophy to Heart Failure, J. Am. Coll. Cardiol. 28, 506–514.
Kaul, N., Siveski-Iliskovic, N., Thomas, T.P., Hill, M., Khaper, N., and Singal, P.K. (1995) Probucol Improves Antioxidant Activity and Modulates Development of Diabetic Cardiomyopathy, Nutrition 11, 551–554.
Ylä-Herttuala, S., Palinski, W., Rosenfeld, M.E., Parthsarathy, S., Carew, T.E., Butler, S., Witztum, J.L., and Steinberg, D. (1989) Evidence for the Presence of Oxidatively Modified Low Density Lipoprotein in Atherosclerotic Lesions of Rabbit and Man, J. Clin. Invest. 84, 1086–1095.
Navab, M., Berliner, J.A., Watson, A.D., Hama, S.Y., Territo, M.C., Lusis, A.J., Shih, D.M., Van Lenten, B.J., Frank, J.S., Demer, L.L., et al. (1996) The Yin and Yang of Oxidation in the Development of the Fatty Streak. A Review Based on the 1994 George Lyman Duff Memorial Lecture, Arterioscler. Thromb. Vasc. Biol. 16, 831–842.
Basu, S. (1998) Radioimmunoassay of 8-Iso-prostaglandin F2α: An Index for Oxidative Injury via Free Radical Catalysed Lipid Peroxidation, Prostaglandins Leukot. Essent. Fatty Acids 58, 319–325.
Manson, J.E., Gaziano, J.M., Jonas, M.A., and Hennekens, C.H. (1993) Antioxidants and Cardiovascular Disease: A Review, J. Am. Coll. Nutr. 12, 426–432.
Stephens, N.G., Parsons, A., Schofield, P.M., Kelly, F., Cheeseman, K., and Mitchinson, M.J. (1996) Randomised Controlled Trial of Vitamin E in Patients with Coronary Disease: Cambridge Heart Antioxidant Study (CHAOS), Lancet 347, 781–786.
Yusuf, S., Dagenais, G., Pogue, J., Bosch, J., and Sleight, P. (2000) Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients. The Heart Outcomes Prevention Evaluation Study Investigators, N. Engl. J. Med. 342, 154–160.
Esterbauer, H., Puhl, H., Dieber-Rotheneder, M., Waeg, G., and Rabl, H. (1991) Effect of Antioxidants on Oxidative Modification of LDL, Ann. Med. 23, 573–581.
Lerner, D.J., and Kannel, W.B. (1986) Patterns of Coronary Heart Disease Morbidity and Mortality in the Sexes: A 26-Year Follow-up of the Framingham Population, Am. Heart J. 111, 383–390.
Kannel, W.B., Hjortland, M.C., McNamara, P.M., and Gordon, T. (1976) Menopause and Risk of Cardiovascular Disease: The Framingham Study, Ann. Intern. Med. 85, 447–452.
Malmqvist, K., Kahan, T., Edner, M., Held, C., Hägg, A., Lind, L., Müller-Brunotte, R., Nyström, F., Öhman, K.P., Osbakken, M.D., and Ostergern, J. (2001) Regression of Left Ventricular Hypertrophy in Human Hypertension with Irbesartan, J. Hypertens. 19, 1167–1176.
Höglund, C., Alam, M., and Thorstrand, C. (1988) Atrioventricular Valve Plane Displacement in Healthy Persons. An Echocardiographic Study, Acta Med. Scand. 224, 557–562.
Teichholz, L.E., Kreulen, T., Herman, M.V., and Gorlin, R. (1976) Problems in Echocardiographic Volume Determinations: Echocardiographic-Angiographic Correlations in the Presence of Absence of Asynergy, Am. J. Cardiol. 37, 7–11.
Randall, O.S., Westerhof, N., van den Bos, G.C., and Alexander, B. (1986) Reliability of Stroke Volume to Pulse Pressure Ratio for Estimating and Detecting Changes in Arterial Compliance. J. Hypertens. (Suppl.) 4, S293-S296.
Boberg, M., Croon, L.B., Gustafsson, I.B., and Vessby, B. (1985) Platelet Fatty Acid Composition in Relation to Fatty Acid Composition in Plasma and to Serum Lipoprotein Lipids in Healthy Subjects with Special Reference to the Linoleic Acid Pathway, Clin. Sci. 68, 581–587.
Öhrvall, M., Tengblad, S., and Vessby, B. (1993) Lower Tocopherol Serum Levels in Subjects with Abdominal Adiposity, J. Intern. Med. 234, 53–60.
Thurnham, D.I., Davies, J.A., Crump, B.J., Situnayake, R.D., and Davis, M. (1986) The Use of Different Lipids to Express Serum Tocopherol: Lipid Ratios for the Measurement of Vitamin E Status, Ann. Clin. Biochem. 23, 514–520.
Öhrvall, M., Tengblad, S., Ekstrand, B., Siegbahn, A., and Vessby, B. (1994) Malondialdehyde Concentration in Plasma Is Inversely Correlated to the Proportion of Linoleic Acid in Serum Lipoprotein Lipids, Atherosclerosis 108, 103–110.
Lind, L., Andersson, P.E., Andrén, B., Hänni, A., and Lithell, H.O. (1995) Left Ventricular Hypertrophy in Hypertension Is Associated with the Insulin Resistance Metabolic Syndrome, J. Hypertens. 13, 433–438.
Morrow, J.D., Frei, B., Longmire, A.W. Gaziano, J.M., Lynch, S.M., Shyr, Y., Strauss, W.E., Oates, J.A., and Roberts, L.J., 2nd (1995) Increase in Circulating Products of Lipid Peroxidation (F2-isoprostanes) in Smokers. Smoking as a Cause of Oxidative Damage, N. Engl. J. Med. 332, 1198–1203.
Gupta, M., and Singal, P.K. (1989) Higher Antioxidative Capacity During a Chronic Stable Heart Hypertrophy. Circ. Res. 64, 398–406.
Grimsgaard, S., Bonaa, K.H., Hansen, J.B., and Myhre, E.S. (1998) Effects of Highly Purified Eicosapentaenoic Acid and Docosahexaenoic Acid on Hemodynamics in Humans, Am. J. Clin. Nutr. 68, 52–59.
Ghatak, A., Brar, M.J., Agarwal, A., Goel, N., Rastogi, A.K., Vaish, A.K., Sircar, A.R., and Chandra, M. (1996) Oxy Free Radical System in Heart Failure and Therapeutic Role of Oral Vitamin E, Int. J. Cardiol. 57, 119–127.
Ganau, A., Devereux, R.B., Roman, M.J., de Simone, G., Pickering, T.G., Saba, P.S., Vargiu, P., Simongini, I., and Laragh, J.H. (1992) Patterns of Left Ventricular Hypertrophy and Geometric Remodeling in Essential Hypertension, J. Am. Coll. Cardiol. 19, 1550–1558.
Lin, W.W., Chen, Y.T., Hwang, D.S., Ting, C.T., Wang, K.Y., and Lin, C.J. (1999) Evaluation of Arterial Compliance in Patients with Carotid Arterial Atherosclerosis, Chung Hua I Hsueh Tsa Chih (Taipei) 62, 598–604.
Sharrett, A.R., Patsch, W., Sorlie, P.D., Heiss, G., Bond, M.G., and Davis, C.E. (1994) Associations of Lipoprotein Cholesterols, Apolipoproteins A-I and B, and Triglycerides with Carotid Atherosclerosis and Coronary Heart Disease. The Atherosclerosis Risk in Communities (ARIC) Study, Arterioscler. Thromb. 14, 1098–1104.
Niskanen, L., Rauramaa, R., Miettinen, H., Haffner, S.M., Mercuri, M., and Uusitupa, M. (1996) Carotid Artery Intima-Media Thickness in Elderly Patients with NIDDM and in Nondiabetic Subjects, Stroke 27, 1986–1992.
Crouse, J.R., Goldbourt, U., Evans, G., Pinsky, J., Sharrett, A.R., Sorlie, P., Riley, W., and Heiss, G. (1996) Risk Factors and Segment-Specific Carotid Arterial Enlargement in the Atherosclerosis Risk in Communities (ARIC) Cohort, Stroke 27, 69–75.
Ferrieres, J., Elias, A., Ruidavets, J.B., Cantet, C., Bongard, V., Fauvel, J., and Boccalon, H. (1999) Carotid Intima-Media Thickness and Coronary Heart Disease Risk Factors in a Low-Risk Population, J. Hypertens. 17, 743–748.
Ma, J., Folsom, A.R., Lewis, L., and Eckfeldt, J.H. (1997) Relation of Plasma Phospholipid and Cholesterol Ester Fatty Acid Composition to Carotid Artery Intima-Media Thickness: The Atherosclerosis Risk in Communities (ARIC) Study, Am. J. Clin. Nutr. 65, 551–559.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Steer, P., Millgård, J., Sarabi, D.M. et al. Cardiac and vascular structure and function are related to lipid peroxidation and metabolism. Lipids 37, 231–236 (2002). https://doi.org/10.1007/s11745-002-0885-3
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-002-0885-3